Evidence map›Paper›PMID 34506723›Full record

ArticleNeuron2021

Cocaine shifts dopamine D2 receptor sensitivity to gate conditioned behaviors.

Sheng Gong, Nicholas Fayette, Jasper A Heinsbroek, Christopher P Ford

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Neuron, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. D2 autoreceptors gate vulnerability to cocaine use disorder.bioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in striatum and biases against heavy persistent alcohol drinking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sheng GongDepartment of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, USA.
Nicholas FayetteDepartment of Anesthesiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Jasper A HeinsbroekDepartment of Anesthesiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA.
Christopher P FordDepartment of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: christopher.ford@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · US

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0M
Encoding Dopamine Signals in the Mesolimbic SystemR01DA035821 · NIDA · UNIVERSITY OF COLORADO DENVER · PI FORD, CHRISTOPHER PETER · 2013 to 2023
$3.5M
Regulation of striatal acetylcholine transmission by cholinergic interneuronsR01NS095809 · NINDS · UNIVERSITY OF COLORADO DENVER · PI FORD, CHRISTOPHER PETER · 2016 to 2024
$3.4M
Validating and extending optical tools for extended neural silencingUF1NS107710 · NINDS · UNIVERSITY OF COLORADO DENVER · PI FORD, CHRISTOPHER PETER, KENNEDY, MATTHEW J · 2018 to 2018
$2.0M
Dissecting Ventral Pallidal Subcircuit Contributions to Drug Seeking in AddictionDP5OD026407 · OD · UNIVERSITY OF COLORADO DENVER · PI HEINSBROEK, JASPER · 2019 to 2023
$1.9M
Stress induced plasticity of excitatory inputs to the LCR21MH123085 · NIMH · UNIVERSITY OF COLORADO DENVER · PI FORD, CHRISTOPHER PETER · 2020 to 2020
$428k
NIDA NIH HHS P30 DA048736NIDA NIH HHS R01 DA035821NIH HHS DP5 OD026407NIMH NIH HHS R21 MH123085NINDS NIH HHS R01 NS095809NINDS NIH HHS UF1 NS107710
6 · The paper itself

Abstract

Cocaine addiction is a chronic, relapsing disorder characterized by maladaptation in the brain mesolimbic and nigrostriatal dopamine system. Although changes in the properties of D2-receptor-expressing medium spiny neurons (D2-MSNs) and connected striatal circuits following cocaine treatment are known, the contributions of altered D2-receptor (D2R) function in mediating the rewarding properties of cocaine remain unclear. Here, we describe how a 7-day exposure to cocaine alters dopamine signaling by selectively reducing the sensitivity, but not the expression, of nucleus accumbens D2-MSN D2Rs via an alteration in the relative expression and coupling of G protein subunits. This cocaine-induced reduction of D2R sensitivity facilitated the development of the rewarding effects of cocaine as blocking the reduction in G protein expression was sufficient to prevent cocaine-induced behavioral adaptations. These findings identify an initial maladaptive change in sensitivity by which mesolimbic dopamine signals are encoded by D2Rs following cocaine exposure.

Indexed as

CocaineCocaine-Related DisordersAnimalsMiceMice, TransgenicNucleus AccumbensReceptors, Dopamine D1Receptors, Dopamine D2CocaineReceptors, Dopamine D1Receptors, Dopamine D2addictionbasal gangliaGPCRG proteinmetabotropicpsychostimulant

Identifiers

PMID34506723
PMCPMC8571051
OpenAlexW3198410291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.